Xspray Pharma signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc
UpScriptHealth™ is a comprehensive, direct-to-consumer telehealth and virtual prescribing platform that is innovating the way customers get the medications they need
EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults
EVERSANA, the leading provider of global services to the life sciences industry, continues to use proven integrated commercialization strategies driven by cutting-edge technologies and faster, real-time data
OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders
In preparation for launch, Resverlogix will utilize EVERSANA’s fully integrated commercialization services
Hub Service Providers first quarter 2021 activities include new solutions and acquisitions and investments
Datavant’s technology allows its partners to link the patient datasets together to build a longitudinal history without knowing the identity of those patients